case of TDF, it is due to the fact that investigators have encountered difficulties in clinical practice with respect to reliability and validity of commercially available systems. 36, 44 Recently, a novel TD microprobe has been devised for the continuous, minimally invasive, and real-time monitoring of regional tissue perfusion. In comparison to previous TD sensors, this microprobe has been reduced in size, is implanted intraparenchymally, and is based on advanced mathematical modeling systems. 30, 38 Previous ex vivo studies, in which the radioactive microsphere technique was used as a reference method, have demonstrated that the technique measures tissue perfusion reliably in absolute flow values throughout the physiological range (0-200 ml/100 g/min). 38 In addition, the TD microprobe has been successfully applied in humans to monitor liver and kidney blood flow over a time period of up to 7 days. 30 In the present study, we introduce this TD microprobe as a novel, minimally invasive technique to measure cerebral perfusion. In a sheep model, its dynamic response to standard physiological variations of CBF is evaluated and compared with LDF, the experimental reference method, for accurate real-time assessment of relative rCBF changes. 16, 17 However, because a comparison of TDF and LDF does not allow for validation of absolute rCBF values, the TD microprobe was implanted into brain-injured patients, and TD-rCBF values were validated by comparing them with those obtained using the sXe-CT technique. 51 The results show that use of the novel TD microprobe represents an accurate, reliable, and sensitive technique to monitor intraparenchymal rCBF online continuously at the bedside and to detect even minor flow changes rapidly.
Materials and Methods

Experimental Validation
Animal Preparation. The study was approved by the animal care and use committee of the local government authorities. Experiments were performed in 16 adult farm-bred sheep of either sex (weight 40.6 Ϯ 3.5 kg). Following premedication with intravenous xylazine hydrochloride (5 mg), anesthesia was induced and maintained using intravenous ketamine (10-15 mg/kg/hr) and midazolam (0.5-1 mg/kg/hr). Muscular paralysis was achieved by administration of pancuronium (0.12 mg/kg/hr). The animals were ventilated using a ventilator that was adjusted to yield a PaCO 2 of 35 to 40 mm Hg and a PaO 2 greater than 150 mm Hg. After the animal was placed in a supine position, a No. 7.5 French percutaneous sheath introducer was established in the left internal jugular vein for intravenous administration of fluids and drugs. Two fluidfilled No. 8.5 French single-lumen catheters were inserted into the descending aorta via the femoral arteries for monitoring of arterial pressure and sampling of arterial blood. Lactated Ringer's solution was given continuously (2-4 ml/kg/hr), as indicated by cardiac filling pressure. For hemodynamic monitoring, we used pressure transducers referenced to atmospheric pressure at the midthorax level. Body temperature was maintained between 36˚C and 38˚C.
Next, the animal was turned to the prone position and the head was immobilized in a head holder. A longitudinal midline incision was made along the vertex and a burr hole, 10 to 15 mm in diameter, was opened in the frontal area of the skull, 20 mm from the midline, on the coronal suture by using a high-speed electric drill. After opening the dura, both TD and LD microprobes were placed intracerebrally through the burr hole at a depth of 20 mm below the dura. The distance between the tips of the probes was kept at approximately 10 mm to exclude interference of the two methods. To stabilize the probes in their positions, each was inserted through a piece of bone wax that was molded into and around the burr hole. Previous pilot studies had demonstrated that by using this implantation technique, probes are localized subcortically within the white matter of the frontal lobe, lateral to the ventricular system.
Monitoring of Physiological Parameters and Blood Gases.
During the experiments, all hemodynamic and ventilatory variables were continuously recorded using a Pentium II computer, an analog-to-digital card, and graphic programming software. Arterial blood gas analyses were performed intermittently by using a blood gas analyzer.
Thermal Diffusion Flowmetry. The TD microprobe contains two thermistors (distance 5 mm) embedded in a flexible medicalgrade polyurethane catheter (diameter 0.9 mm; Fig. 1 ). The distal thermistor is heated to approximately 2˚C above the tissue baseline temperature and establishes a constant spherical temperature field approximately 4 mm in diameter. The proximal sensor, which is located outside the thermal field, monitors tissue temperature and compensates for baseline fluctuations. The power dissipated by the heated thermistor (0.005-0.01 W) provides a direct measure of the tissue's ability to transport heat. Because thermal transfer takes into account both the intrinsic conductive properties of the tissue and the convective effects of perfusion, the thermal conduction and convection components have to be separated to realize an accurate and reproducible blood flow measurement in absolute physiological values. In earlier applications of heated probes, this was achieved by performing calibration procedures during no-flow conditions. This condition, however, presents obvious limitations when applied in a clinical situation. The present system, instead, uses a series of data reduction algorithms that permit reliable quantification of tissue perfusion without a no-flow calibration by determining the conductive properties of the tissue from the initial rate of propagation of the thermal field and separating this component from the total heat transfer to determine the thermal convection component. 38 The sample volume of the probe corresponds to the volume of the temperature field and approximates 27 mm 3 . For the present study TD-rCBF was recorded online at a sampling rate of 1 Hz.
Laser Doppler Flowmetry. As repeatedly demonstrated, LDF is considered the gold-standard technique for instantaneous, continuous, and real-time measurements of rCBF as well as for an accurate assessment of relative rCBF changes (sample volume approx- fluctuations in tissue perfusion. The major drawback of this technique is its inability to provide rCBF values in absolute flow values (ml/100 g/min). 16, 17 The LD flowmeter selected for the present study uses a 2-mW helium-neon laser light with a wavelength of 780 nm, led by an optical fiber to a microprobe having a diameter of 0.5 mm. At the beginning of each experiment, the LD flowmeter was calibrated against a standardized latex solution, as recommended by the manufacturer. Laser Doppler rCBF was recorded online at a sampling rate of 1 Hz.
Experimental Protocol. Following surgery and probe implantation, a 30-minute accommodation period was allowed before a 15-minute baseline recording was performed. Further experimental procedures were initiated only after stable and reliable TD-rCBF and LD-rCBF signals had been obtained. Blood gas analysis had to reveal physiological values. To compare the CBF response to standardized challenges, the animals were divided into two groups and subjected to a series of physiological tests: in Group I (eight animals), cerebrovascular CO 2 reactivity and cardiac arrest were assessed; in Group II (eight animals), cerebrovascular autoregulation was studied followed by cardiac arrest.
Carbon Dioxide Reactivity. Following the baseline recordings, hypercapnia was induced either by normoxemic hypoventilation (four animals) or by subsequent inhalation of 7% CO 2 balanced with O 2 (four animals). Blood gas analyses were performed every 10 minutes. When a PaCO 2 greater than 60 mm Hg was achieved, ventilation parameters were kept constant and recordings during hypercapnia were continued until TD-rCBF and LD-rCBF reached stable plateaus. The animals were then normoventilated again until normocapnia was reestablished. In a third phase, the animals were hyperventilated for 15 minutes by increasing the ventilation rate and tidal volume to achieve hypocapnia (PaCO 2 Ͻ 30 mm Hg). Finally, ventilation was normalized again and another stabilizing period was allowed.
Autoregulation of CBF. Following the baseline recordings, MABP was lowered gradually by shedding blood at a rate of approximately 30 ml/minute to a final MABP of approximately 30 mm Hg. At this plateau, rCBF was recorded for 15 minutes without further manipulations. Then MABP was raised by continuous reinfusion of autologous blood at a rate comparable to the shedding rate. When the MABP returned to baseline values, L-norepinephrine was infused to increase the MABP further to approximately 200 mm Hg. After readings of rCBF remained stable for 5 minutes, the infusion was terminated and the MABP was allowed to return to baseline.
No Flow Induced by Cardiac Arrest. At the end of the experimental procedures, the animals were killed by sequential administration of propofol, phenobarbital, and saturated KCl solution. When electrocardiography indicated termination of cardiac activity, the TD-rCBF was validated for no-flow conditions and the biological zero for LDF was recorded.
Histological Study. After the death of the animal, the microprobes were removed and the brain was explanted from the skull and fixed by immersion in 4% formalin solution. Small tissue blocks containing the tracks of the probes were dissected and embedded in paraffin. For conventional histological study 5-m sections along the tracks were stained with hematoxylin and eosin.
Clinical Validation
Patients and Probe Implantation. The clinical part of the study was approved by the local research ethics committee. A total of 16 patients older than 18 years of age had sustained a severe traumatic head injury (two patients) or subarachnoid hemorrhage (14 patients), and had a Glasgow Coma Scale score less than 8 and were entered into the study. After admission, all patients underwent placement of a ventriculostomy or intraparenchymal sensor for ICP monitoring. Patients remained paralyzed, sedated, and ventilated, and were treated according to a standardized ICP-directed management protocol.
At the time the ICP-monitoring system was placed, a one-way bolt was inserted through a 3.2-mm coronal burr hole over the nonaffected or less affected hemisphere. The TD microprobe was inserted through the bolt, placed subcortically (white matter) at a depth of 20 mm below the level of the dura, and secured by tightening the bolt. A postoperative CT scan was obtained after implantation to assess probe position and probe-related complications. The probe was removed as soon as the patients were allowed to awaken.
Stable Xenon-Enhanced CT Scanning. The sXe-CT technique is accepted as a gold-standard clinical technique for CBF measurements. 51 The method is based on the Kety-Schmidt principle, assuming that the rate of uptake and the rate of clearance of an inert substance are proportional to the blood flow in the tissue. 51 In brief, two baseline CT scans were obtained at the level of the tip of the microprobe, which could easily be identified due to its radiodensity. Next, the patients were ventilated using a 30% Xe/70% O 2 mixture for 4.5 minutes, and six xenon-enhanced scans were obtained through this region. The thickness of each scan for CBF measurements was 10 mm. The Xe concentration in blood was derived from the expired end-tidal Xe concentration and converted into Hounsfield units by using a hematocrit. The baseline scan pairs were averaged and subtracted from each of the enhancement images to derive a curve of enhancement over time. Finally, a CBF map was calculated from the arterial and tissue Xe time curves by using the Kety-Schmidt equation. For TD-rCBF validation, rCBF was evaluated by placing a circular ROI of 500 voxels (approximately 5 cm 3 ; 1 voxel = 1 ϫ 1 ϫ 10 mm 3 ) around the artifact of the microprobe tip (sXe-rCBF). As previously demonstrated, the system error of rCBF measurements even in low-flow states is less than 12% when using this approach. 51 Clinical Protocol. Following probe implantation and confirmation of its correct position on CT scanning, a baseline TD-rCBF measurement was obtained while the patient was in the intensive care unit. Twenty-four hours after probe implantation, an sXe-CT scan was routinely obtained in each patient. Thereafter additional sXe-rCBF studies were performed, depending on the individual clinical course of each patient, to rule out cerebral hypoperfusion and hyperperfusion, as well as to guide CBF-based therapies. To perform a direct comparison of the two CBF techniques under identical macro-and microhemodynamic conditions, TD-rCBF and sXe-rCBF measurements were simultaneously obtained while the patient was within the CT scanner unit. The TD-rCBF measurement was initiated as soon as the end-tidal curve of Xe had reached the 30% plateau.
Data Handling and Statistical Analysis. Physiological parameters, arterial blood gases, and CBF values are given as the means Ϯ SD. Both TD-rCBF and sXe-rCBF are expressed in absolute flow values (ml/100 g/min) and LD-rCBF is expressed as the relative change from baseline readings (100%) that were defined at the beginning of each experimental phase.
For graphic presentation and interpretation of quantitative data obtained during the sheep experiments, rCBF measurements during normocapnia and hypocapnia are plotted against time in 200-second epochs. For each time point, TD-rCBF and LD-rCBF signals were averaged over 10 seconds. In contrast, because the time needed to reach an rCBF plateau during hypercapnia varied considerably among animals, the time between induction of hypercapnia and reaching the rCBF plateau was divided into 10 relative time epochs ranging from t 0 (baseline) to t 1 (rCBF plateau).
The relationship between rCBF and MABP was evaluated, displaying the mean TD-rCBF and LD-rCBF values and the corresponding MABP value. 13 The MABP is represented in 10-mm Hg increments. The lower and upper pressure limits of autoregulation were defined as MABP values, whenever rCBF dropped below 80% and exceeded 120% of baseline blood flow. 17 The rCBF value obtained during the initial baseline reading was defined as 100% rCBF. In addition, an autoregulation index for TD-rCBF ([ml/100 g/ min]/mm Hg) was calculated below, within, and beyond the pressure limits of autoregulation.
To compare the response time of the TD system with the LDF system during rapid changes of cerebral perfusion, the T 50 for TDrCBF and LD-rCBF was assessed during recovery from hypercapnia as well as during cardiac arrest. Comparisons of dependent variables were tested using the paired Student t-test. Correlation and agreement between TD-rCBF and sXe-rCBF were assessed by univariate linear regression analysis and the graphic model proposed by Bland and Altman, 4 respectively. Probability values less than 0.05 and 0.01 were considered to be significant and highly significant, respectively.
Sources of Supplies and Equipment
The TD microprobe was manufactured by Thermal Technologies, Inc. (Cambridge, MA). During the animal experiments, the sheep were ventilated using a Servo Ventilator 300 manufactured by Siemens-Elema AB (Solna, Sweden). The No. 7.5 French percutaneous sheath introducer and the No. 8.5 French single-lumen catheters were obtained from Arrow International (Reading, PA). Lactated Ringer's solution was purchased from Delta-Pharma (Pfullingen, Germany). To monitor hemodynamics, we used Novotrans II pressure transducers and a Sirecust 1281 monitor, manufactured by Medex (Hilliard, OH) and Siemens Medical Electronics (Danvers, MA), respectively. Lab-View graphics programming software (National Instruments, Austin, TX) was used to record physiological parameters, and arterial blood gases were analyzed using an ABL300 blood gas analyzer (Radiometer A/S, Copenhagen, Denmark). The DRT4 LD flowmeter was purchased from Moore Instruments, Ltd. (Millwey, UK). The bolt through which the TD microprobe was placed was obtained from DID Medical (Simbach am Inn, Germany).
Results
Experimental Validation
Implantation of the microprobes in sheep brains was uneventful. With rigid fixation to the bone, stable measurements could be obtained throughout all 3-to 5-hour experiments.
Carbon Dioxide Reactivity. The physiological parameters and the results of the arterial blood gas analyses obtained during the CO 2 reactivity tests are represented in Table 1 . Figure 2 illustrates a representative original registration of TD-rCBF and LD-rCBF during evaluation of the CO 2 reactivity. The TD microprobe revealed a similar temporal resolution and sensitivity for changes in cerebral perfusion as the reference method. Hypercapnia caused a sigmoid increase in rCBF from 49.3 Ϯ 15.8 ml/100 g/min to 119.6 Ϯ 47.3 ml/100 g/min (142%, p Ͻ 0.01; Fig. 3 ). The mean time to reach the rCBF plateau (t 1 ) was approximately 1300 seconds (range 622-1740 seconds). Return to normocapnia resulted in a rapid parallel decrease in TD-rCBF and LD-rCBF, returning to baseline values within 10 minutes (Fig. 3) . During this decay in cerebral perfusion, the T 50 for TD-rCBF was 134 Ϯ 51 seconds and the T 50 for LD-rCBF was 136 Ϯ 48 seconds. Hypoventilation, in contrast, caused only a moderate decrease in TDrCBF from 51.2 Ϯ 12.8 ml/100 g/min to 39.3 Ϯ 5.6 ml/ 100 g/min (Ϫ23%, p Ͻ 0.05; Fig. 3) . Again, the dynamics of the TD-rCBF changes corresponded well to the dynamics of the LDF readings.
Cerebral Autoregulation. We analyzed whether the TD system is suited to a direct assessment of cerebrovascular autoregulation. Variations in MABP between 30 mm Hg and 200 mm Hg revealed almost identical S-shaped relationships between MABP and TD-rCBF, as well as between MABP and LD-rCBF (Fig. 4) . In both curves, the upper and lower pressure limits were approximately 65 mm Hg and approximately 170 mm Hg, respectively. Autoregulation indices for TD-rCBF below and above the limits of autoregulation were 0.44 (ml/100 g/min)/mm Hg and 0.39 (ml/ 100 g/min)/mm Hg, suggesting that a 10-mm Hg change in MABP led to a 4.4-ml/100 g/min decrease and 3.9-ml/100 g/min increase in TD-rCBF, respectively. Within the limits of autoregulation, however, the same MABP change resulted in a TD-rCBF increase of only 1.8 ml/100 g/min.
No Flow Induced by Cardiac Arrest. When the animals were killed, the mean time to cardiac arrest was 205 seconds (range 97-298 seconds). The T 50 for TD-rCBF and LD-rCBF was 31 Ϯ 18 seconds and 46 Ϯ 22 seconds, respectively. At no-flow conditions a TD-rCBF of 0 ml/100 g/min was demonstrated in all animals.
Histological Studies
Correct probe position within the subcortical white matter could be confirmed in all animals. Histological analysis of the probes' tracks revealed only minimal tissue destruction, no signs of local inflammation or evidence of edema, and no signs of thermal damage according to the criteria of Lyons, et al. 31 Furthermore, histological examination did not reveal intraparenchymal hemorrhage surrounding the tracks, and only a few extravascular red blood cells were observed (Fig. 5) . Identical results were obtained when analyzing the tracks of the LDF probes (data not shown).
Clinical Validation
Microprobe Implantation and Flow Characteristics in Humans. Probe-related complications after implantation into patients, such as intracerebral hemorrhage or increased infection rate, were not observed. The high radiodensity of the probe allowed for its accurate detection on CT scans and confirmation of correct probe position within the subcortical parenchyma of the frontal lobe. Displacement of the probe did not occur during the implantation period, which ranged from 2 to 15 days. Initial TD-rCBF readings after implantation were stable and reliable, with a mean value of 34.8 Ϯ 9.8 ml/100 g/min.
As previously shown, cerebral perfusion may demonstrate a cycling pattern of CBF, with changing amplitude and peak frequency. 16, 24 Thus, the characteristics of the TD microprobe were further assessed by examining its capability of assessing this kind of rhythmic flow oscillation in humans. As illustrated in Fig. 6 , the system could detect cyclic changes in cerebral perfusion. The degree of flow oscillations and amplitude, however, varied considerably among individual patients.
Comparison of TD-rCBF and sXe-rCBF. A total of 32 simultaneous TD-rCBF and sXe-rCBF measurements (range one-four measurements/patient) was performed. The sXe-rCBF ranged from 18 to 63 ml/100 g/min. The CT artifact caused by the tip of the TD microprobe was minimal and did not interfere with sXe-rCBF measurements (Fig. 7) . The mean TD-rCBF and sXe-rCBF values during the validation experiments were 34.3 Ϯ 11.6 ml/ 100 g/min and 35.4 Ϯ 10.3 ml/100 g/min, respectively.
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Monitoring of CBF by thermal diffusion flowmetry Linear regression analysis revealed an excellent correlation between the two techniques with a slope of the regression line close to the line of equality (Fig. 8) . A comparison of the two CBF techniques according to the method of Bland and Altman 4 revealed a mean difference of 1.1 Ϯ 5.2 ml/100 g/min. All individual differences were scattered within the limits of agreement (mean Ϯ 2 SD; Fig.  8 ). Because their scattering did not vary over the range of rCBF values, a systematic relationship between measurement error and true value could be excluded.
To validate the TD system further, intraindividual changes in TD-rCBF between two repeated measurements were correlated with changes in sXe-rCBF (repeated measurements were obtained using the same microprobe within the identical implantation site). As illustrated in Fig. 9 , this regression analysis confirmed the strong relationship between both rCBF techniques.
Discussion
In the present study, a novel TD-based method that allows for a continuous, minimally invasive, and real-time assessment of rCBF in absolute flow values has been evaluated. An experimental validation comparing this method with LDF during a series of standardized CBF variations has revealed that the system has a high temporal resolution and a high sensitivity to even minor flow changes which is mandatory for monitoring CBF regulation and dynamics under both physiological and pathological conditions. Furthermore, the method has been introduced into clinical practice with a characterization of TD-rCBF measurements in neurosurgical patients and has been validated by comparing it with the sXe-CT method.
Techniques to Measure CBF
Zauner and coworkers 52 summarized the criteria of the ideal method for monitoring brain injured patients as follows: it should be continuous, quantitative, applicable to bedside use, sensitive enough to detect harmful events, non-or minimally invasive, robust, user friendly, and cost effective. In fact, none of the techniques that are currently used to measure CBF clinically meet these criteria. Crosssectional CBF techniques, such as sXe-CT and positron emission tomography, cannot be routinely performed at the bedside and only provide a "snap-shot" view of flow. Similarly, indicator methods that are applicable to bedside use represent discontinuous methods that allow repeated examinations in 30-to 60-minute intervals at best and often require the use of radioactive and expensive tracers (for example, 133 Xe inhalation and injection methods). On the other hand, continuous bedside methods have failed to assess CBF reliably. Transcranial Doppler ultrasonography assesses flow velocity in major intracerebral vessels rather than tissue perfusion and microcirculation. 5 Laser Doppler flowmetry reveals information on rCBF only in relative terms and is prone to artifacts produced by patient movement or probe displacement, which limits its clinical applicability. 2, 40 In fact, TDF is currently the only technique that has been shown to allow for a continuous and quantitative assessment of regional tissue perfusion.
Evolution of TDF
Gibbs and coworkers 19 were the first to demonstrate that changes in CBF could be detected with the use of a heated thermocouple. Since then many investigators have developed thermal systems to measure rCBF, although they were initially limited to an assessment of flow in arbitrary units and, thus, changes of flow in relative terms. 11 The major obstacle to quantification of blood flow at the time was the inability to separate the tissue's heat-transfer ability into its thermal-conductive and flow-related thermalconvective components, which represents the key to a successful clinical routine application. In 1973, Carter and Atkinson 8 for the first time reported on a thermal sensor based on a Peltier stack, with which they were able to measure blood flow in quantitative values. The system was subsequently refined and today actually consists of two gold discs (6 mm and 3 mm in diameter) mounted 4 mm apart on a silastic leaf (approximately 60 mm in length and 8 mm in width) that is placed onto the cortical surface to monitor regional cortical blood flow. 7, 20 Advantages of this technique are that the probe does not invade the brain tissue and allows for a quantitative assessment of cortical gray matter flow. Although several investigators reported on reliable regional cortical blood flow measurements, 9, 14, 20 this technique has failed thus far to gain broad acceptance, in part because of some technical and methodological difficulties. 36, 44 Among these are the relatively high invasiveness of the technique, which requires a small craniotomy;
6,45 the risk of brain-tissue damage when retrieving the sensor; the potential loss of direct cortical contact in the case of brain atrophy, underlying sulci, subdural hematoma, or positioning of the patient's head; and the lack of successful validation of the method in braininjured patients when applying quantitative CBF techniques. 44 With this in mind, several further attempts have been undertaken to apply heat-transfer characteristics to a continuous assessment of tissue perfusion. 1, 10, 49 However, none of these techniques has reached a state at which it could be transferred from bench to bedside.
Discussion of the New Method
The present system is based on isothermal principles, which implies that the thermal field around the probe is kept constant by a variable heating power that is directly related to the tissue heat transfer. The size of the probe has been reduced to less than 1 mm, providing a design that is comparable to other minimally invasive microprobes already established in a clinical setting, such as intraparenchymal ICP sensors, tissue O 2 sensors, or microdialysis catheters. Like these, the microprobe can be implanted into the parenchyma at any depth and can thus assess either white, mixed subcortical, or deep gray matter rCBF. Compared with epicortical placement, this consequently avoids failure caused by loss of direct cortical contact. Finally, the probe may be used to assess rCBF within the same region that is currently monitored for tissue oxygenation and metabolism. This is important for the integration of rCBF measurements into future multimodal neuromonitoring. However, the present system also has some limitations: the probe invades the brain tissue to a minimal extent and is not suitable for a reliable assessment of cortical gray matter flow.
Experimental Validation
To analyze the temporal resolution of the TD system, LDF has been used as a reference method because it provides a continuous estimate of rCBF and is an established technique in the study of dynamics of changes in cerebral perfusion. 16, 17 In contrast to previous studies in which LDF probes were placed on the cortical surface, intraparenchymal microprobes have been used in this study to assess rCBF within the same environment as the TD microprobe, that is, subcortically. Despite theoretical sources of error due to edema formation or microhemorrhages, intraparenchymal application of LDF, and similar invasive techniques, have been shown to provide good quality signals from brain tissue of larger animals and preservation of cerebral vasoreactivity. 29, 43, 47 Our functional and histological results suggest that the same is true for the TD microprobe: probe implantation and heating of tissue apparently did not affect the cerebrovascular reactivity and structural integrity of the surrounding tissue.
The novel TD microprobe has been shown to measure rCBF continuously and reliably in absolute flow values. In the present study, both TD-rCBF and LD-rCBF were sampled at a rate of 1 Hz and, therefore, rCBF changes could be registered instantaneously. The dynamics of changes in cerebral perfusion, as assessed by LDF and TDF in response to hypercapnia and hypocapnia corresponded well to each other and were consistent with data in the literature. 18, 21 Moreover, the subcortical TD-rCBF values were in good agreement with published rCBF values obtained during 1 hour of hypercapnia in a sheep model using the radioactive microsphere technique (frontal rCBF at baseline 51 Ϯ 18 ml/100 g/min; at hypercapnia 119 Ϯ 40 ml/100 g/min). 50 Besides, the evaluation of the relationship between TD-rCBF and MABP has clearly demon- strated that the TD system is also suited to assess cerebrovascular autoregulation directly. Pressure limits of autoregulation and autoregulation indices for TD-rCBF were comparable with previously published results. 16 The data obtained in this model will provide the basis for a future assessment of cerebrovascular autoregulation in humans under pathological conditions.
Although TD-rCBF values obtained under baseline conditions and during stimulation were in good agreement with published data when expressed in absolute terms, a comparison of relative changes revealed higher values for TD-rCBF when compared with LD-rCBF. This observation is in line with previous reports in which an underestimate of actual tissue flow increase by LDF has been described, compared with the measurement of nutritive blood flow using radioactive-labeled microspheres. 29, 39 This may be due to the fact that LDF assesses cell flux rather than nutritive perfusion or that the LDF signal is obscured by signals other than capillary flux (brownian motion) or large vessel flux. 34, 46, 48 
Clinical Validation
The absolute perfusion values provided by the TD system have been validated by a comparison with the sXe-CT method. This could only be realized because the CT artifacts of the microprobe were negligible and did not interfere with sXe-rCBF measurements. For assessment of sXe-rCBF an ROI of 500 voxels (5 cm 3 ) was chosen. The results of the regression analysis demonstrated a good correlation between the TD system and the sXe-CT method. Good agreement between the two techniques was finally demonstrated by the results of an analysis performed using the Bland and Altman method. 4 It should be noted that these results not only confirmed good agreement between the two techniques but also indicate that subcortical TD-rCBF measurements, despite their relatively small sample volume, are representative of regional tissue perfusion within a volume up to at least 5 cm 3 .
In the present study, the TD microprobe was implanted at a depth of approximately 20 mm below the dura level, an implantation site that is currently used for standard oxygenation and metabolic neuromonitoring. 15, 23, 26, 28, 32, 33, 35, 41, 52 At this depth, the mean TD-rCBF was found to be approximately 35 ml/100 g/min, reflecting a subcortical mixture of white and gray matter flow. As reported by Høedt-Rasmussen 22 gray matter and white matter flows range from 67 to 80 ml/100 g/min and from 18 to 25 ml/100 g/min, respectively, when the mean global CBF is 40 to 50 ml/ 100 g/min. These values have been confirmed by twocompartment analyses using the sXe-CT technique. 42 It is important to note that this heterogeneity of rCBF, depending on implantation site, will demand careful and standardized implantation protocols for future clinical applications of this system.
As demonstrated, the novel TD system not only allows us to assess rCBF in absolute terms but also offers the opportunity to monitor even discrete oscillations in cerebral circulation because of its high temporal resolution and sampling rate. As previously reported, cerebral flow oscillations may occur spontaneously under physiological conditions at frequencies ranging between 0.5 and 11 cycles/ minute 16, 24 with the amplitude of these oscillations ranging up to 30% of the mean CBF value. 16 The origin of these CBF oscillations, however, remains controversial and the same is true for their pathophysiological significance. To date, they have been attributed to spontaneous changes in the diameter of cerebral resistance vessels (spontaneous vasomotion), 3, 25, 27 ICP B-waves, 37 cerebral perfusion pressure, 24 or metabolic autoregulation.
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Conclusions A novel TD microprobe has been validated by experimental and clinical means for the continuous, bedside assessment of rCBF in brain-injured patients. Implantation of the probe resulted in preservation of vascular reactivity and only minimal tissue destruction. The microprobe is characterized by a high temporal resolution and sensitivity for flow changes comparable to those of LDF. Compared with LDF, however, the advantage of this new method is the assessment of rCBF in absolute flow values that are in good agreement with rCBF measurements performed using the sXe-CT method. The results of this study pro- FIG. 8 . A: Correlation of TD-rCBF and sXe-rCBF using an ROI of 500 voxels (linear regression analysis). B: Analysis of agreement according to Bland and Altman between TD-rCBF and sXe-rCBF using an ROI of 500 voxels (plot of the difference between the methods against their mean; 32 simultaneous measurements in 16 patients).
FIG. 9. Correlation of changes in TD-rCBF and changes in sXerCBF between repeated simultaneous measurements in 10 patients using an ROI of 500 voxels. Intraindividual analyses were performed using the same TD microprobe in the identical implantation site (linear regression analysis).
vide the basis for the integration of TD-rCBF measurements into future multimodal neuromonitoring.
